0001661181-20-000029.txt : 20200825 0001661181-20-000029.hdr.sgml : 20200825 20200825163418 ACCESSION NUMBER: 0001661181-20-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200821 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hagopian Henry III CENTRAL INDEX KEY: 0001821822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 201132660 MAIL ADDRESS: STREET 1: C/O ORGANOGENESIS INC., 85 DAN ROAD CITY: CANTON STATE: MA ZIP: 02021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organogenesis Holdings Inc. CENTRAL INDEX KEY: 0001661181 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 DAN ROAD CITY: CANTON STATE: MA ZIP: 02021 BUSINESS PHONE: 781-575-0775 MAIL ADDRESS: STREET 1: 85 DAN ROAD CITY: CANTON STATE: MA ZIP: 02021 FORMER COMPANY: FORMER CONFORMED NAME: Avista Healthcare Public Acquisition Corp. DATE OF NAME CHANGE: 20151215 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-08-21 0001661181 Organogenesis Holdings Inc. ORGO 0001821822 Hagopian Henry III C/O ORGANOGENESIS HOLDINGS INC. 85 DAN ROAD CANTON MA 02021 0 1 0 0 Interim CFO Stock Option (Right to Buy) 4.46 2020-08-21 4 A 0 15000 0 A 2030-08-21 Class A Common Stock 15000 15000 D The option becomes exercisable in equal yearly installments over four years from the date of grant. /s/ Stacie S. Aarestad, Attorney-in-Fact 2020-08-25